Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: Prognostic significance of the dose of CD3+ and CD4+ lymphocytes

Annals of Hematology

Volumn 83, Issue 5, 2004, Pages 295-301

  Vela Ojeda, J ^a,b   Garcia Ruiz Esparza M A ^a   Reyes Maldonado, E ^b   Jimenez Zamudio L ^b   Moreno Lafont, M ^b   Garcia Latorre E ^b   Ramirez Sanjuan E ^b   Montiel Cervantes, L ^a,b   Tripp Villanueva, F ^a   Garcia Leon L D ^a   Ayala Sanchez M ^a   Rosas Cabral, A ^a,b   Avina Zubieta J A ^a   Galindo Rodriguez G ^a   Vadillo Buenfil, M ^a   Salazar Exaire, D ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

CD3; CD4 lymphocytes; Chronic myeloid leukemia; Donor lymphocyte infusion

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD3 ANTIGEN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMATINIB; METHOTREXATE; PREDNISONE;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL CRISIS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC GRAFT REJECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; CYTOPENIA; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LEUKAPHERESIS; LIVING DONOR; LYMPHOCYTE TRANSFUSION; MALE; PRIORITY JOURNAL; PROGNOSIS; TIME;

ADOLESCENT; ADULT; ANTIGENS, CD3; ANTIGENS, CD4; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 2342458294     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0822-y     Document Type: Article

References (33)

1. Alyea EP, Soiffer RJ, Canning C (1998) Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 91:3671-3680
2. Arcese W, Goldman JM, Dárcangelo (1993) Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group. Blood 82:3211-3219
3. Bar BMAM, Achattenberg A, Mesnick EJBM (1993) Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 11:513-519
4. Collins RH, Rogers ZR, Bennett M (1992) Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant 10:391-395
5. Collins RH Jr, Shpilberg O, Drobyski WR (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15:433-444
6. Cullis JO, Schwarer AP, Hughes TP (1992) Second transplant for patients with chronic myeloid leukemia in relapse after original transplant with T-depleted donor marrow: feasibility of busulphan alone for re-conditioning. Br J Med 80:33-39
7. Dazzi F, Szydlo RM, Goldman JM (1999) Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 27:1477-1486
8. Dazzi F, Szydlo RM, Craddock C (2000) Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 95:67-71
9. Dazzi F, Szydlo RM, Cross NCP (2000) Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 96:2712-2716
10. Dazzi F, Szydlo RM, Apperley JF (2002) Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusions. Blood 100:2673-2674
11. Faber LM, Van Der HJ, Goulmy E (1995) Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest 96:877-883
12. Giralt S, Hester J, Huh Y (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 86:4337-4343
13. Goldman JM, Apperley JF, Jones L (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 314:202-207
14. Gómez M, Urbano-Ispizua A, Cervantes F (2002) Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. Haematologica 87:1003-1005
15. Guglielmi C, Arcese W, Dazzi F (2002) Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial dose. Blood 100:397-405
16. Hertenstein B, Wiesneth M, Novotny J (1993) Interferon α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 56:1114-1118
17. Higano CS, Brixey M, Bryant EM (1990) Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect. Transplantation 50:175-177
18. Higano C, Raskind W, Singer F (1992) Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation. Blood 80:1437-1442
19. a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation. Blood 90:2549-2554
20. Horowitz MM, Gale RP, Sondel PM (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562
21. Jiang YZ, Barrett J (1997) The allogeneic CD4+ T cell-mediated graft-versus-leukemia effect. Leuk Lymphoma 28:33-42
22. Kolb HJ, Mittermuller J, Clemm C (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465
23. Lewalle P, Triffet A, Delforge A (2003) Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone Marrow Transplant 31:39-44
24. Mackinnon S, Papadopoulos EB, Carabasi MH (1995) Donor leukocyte infusions for molecular or cytogenetic relapse of CML following allogeneic BMT: graft-versus-leukemia responses with minimal toxicity. Blood 86:566a
25. Mackinnon S, Papadopoulos EB, Carabasi MH (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 86:1261-1268
26. Mackinnon S (2000) Who may benefit from donor leukocyte infusions after allogeneic stem cell transplantation? Br J Haematol 110:12-17
27. Porter DL, Collins Jr RH, Shpilberg O (1999) Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol Blood Marrow Transplant 5:253-261
28. Przepiorka D, Weisdorf D, Martin P (1995) Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825-828
29. Raanani P, Dazzi F, Sohal J (1997) The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukemia patients treated for relapse after allogeneic bone marrow transplantation. Br J Haematol 99:945-950
30. Van Rhee F, Lin F, Cullis JO (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:3377-3383
31. Vela-Ojeda J, Tripp-Villanueva F, Sánchez-Cortés (2000) Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience. Arch Med Res 31:206-209
32. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED (1981) The Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529-1533
33. Zorn E, Wang K, Hochberg E (2002) Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 8:2052-2060